SEARCH

SEARCH BY CITATION

REFERENCES

  • Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M. 1995. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55: 39763981.
  • Band V, Zagetowski D, Kulesa V, Sager R. 1990. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 87: 463467.
  • Bartek J, Durban EM, Hallowes R, Taylor-Papadimitriou J. 1990. Selective immortalization of a phenotypically distinct epithelial cell type by microinjection of SV40 DNA into cultured human milk cells. Int J Cancer 45: 11051112.
  • Bennett WP, Alavanja MCR, Blomeke B, Vähäkangas KH, Castrén K, Welsh JA, Bowman ED, Khan MA, Flieder DB, Harris C. 2000. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 91: 20092014.
  • Bergthorsson JT, Eiriksdottir G, Barkardottir RB, Egilsson V, Arason A, Ingvarsson S. 1995. Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3. Hum Genet 96: 437443.
  • Bernstein L, Ross RK. 1993. Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 4865.
  • Borresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjord J, Ottestad L, Smith-Sorensen B, Hovig E, Malkin D. 1992. Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 52: 32343236.
  • Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, Barrett JC, Kolodner RD, Kunkel TA. 1995. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 55: 60636070.
  • Briand P, Petersen OW, van Deurs B. 1987. A new diploid non-tumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 23: 186188.
  • Byrd PJ, Stankovic T, McConville CM, Smith AD, Cooper PR, Taylor AM. 1997. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22–23. Genome Res 7: 7175.
  • Calaf G, Russo J. 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483492.
  • Calaf G, Zhang PL, Alvarado MV, Estrada S, Russo J. 1995. C-Ha ras enhances the neoplastic transformation of human breast epithelial cells treated with chemical carcinogens. Int J Oncol 6: 511.
  • Carter S, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM. 1994. Loss of heterozygosity at 11q22–q23 in breast cancer. Cancer Res 54: 62706274.
  • Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. 2000. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27: 7594.
  • Chen L-C, Dolibaum C, Smith H. 1989. Loss of heterozygosity on chromosome lq in human breast cancer. Proc Natl Acad Sci USA 86: 72047207.
  • Chen L-C, Kurisu W, Ljung BM, Goldman ES, Moore D 2d, Smith HS. 1992. Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84: 506510.
  • Chen L-C, Matsumura K, Deng G, Kurisu W, Ljung B-M, Lerman MI, Waldman FM, Smith HS. 1994. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res 54: 30213024.
  • Chen X, Danes C, Lowe M, Herliczek TW, Keyomarsi K. 2000. Activation of the estrogen-signaling pathway by p21 WAF1/CIP1 in estrogen receptor negative breast cancer cells. J Natl Cancer Inst 92: 14031413.
  • Connolly KC, Gabra H, Millwater CJ, Taylor KJ, Rabiasz GJ, Watson JE, Smyth JF, Wvllie AH, Jodrell DI. 1999. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer. Cancer Res 59: 28062809.
  • Couch DB. 1996. Carcinogenesis: basic principles. Drug Chem Toxicol 19: 133148.
  • Dahiva R, McCarville J, Lee C, Hu W, Kaur G, Carroll P, Deng G. 1997. Deletion of chromosome 11p15, p12, q22, q23–24 loci in human prostate cancer. Int J Cancer 72: 283288.
  • Dong J-T, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. 1995. KA/1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884886.
  • Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P. 1996. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci USA 93: 1308413089.
  • Garcia I, Brandt D, Weintraub J, Zhou W, Aapro M. 1991. Loss of heterozygosity for the short arm of chromosome 11 (11p15) in human milk epithelial cells immortalized by microinjection of SV40 DNA. Cancer Res 51: 294300.
  • Genuardi M, Tsihira N, Anderson DE, Saunders GF. 1989. Distal deletion of chromosome 1q in ductal carcinoma of the breast. Am J Hum Genet 45: 7389.
  • Greenlee RT, Murray T, Bolden S, Wingo PA. 2000. Cancer statistics 2000. CA Cancer J Clin 50: 733.
  • Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, Egilsson V, Ingvarsson S. 1995. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 72: 696701.
  • Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PG, Kiviniemi H, Newsham I, Cavenee WK, Evans GA. 1994. Losses of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 54: 45864589.
  • Hannigan GE, Bayani J, Weksberg R, Beatty B, Pandita A, Dedhar S, Squire J. 1997. Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15.5–p15.4. Genomics 42: 177179.
  • Hellmold H. 1998. Toxicological and endocrinological aspects of cytochrome P450 in breast and lung. PhD Thesis, Stockholm.
  • Henderson BE, Ross R, Bernstein L. 1988. Estrogens as a cause of human cancer [The Richard and Hinda Rosenthal Foundation Award Lecture]. Cancer Res 48: 246253.
  • Holliday R. 1996. Neoplastic transformation: the contrasting stability of human and mouse cells. Cancer Surv 28: 103115.
  • Hu YF, Russo IH, Zalipsky U, Lynch HT, Russo J. 1997. Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer. In Vitro Cell Dev Biol 33: 495498.
  • Hu YF, Lau KM, Ho SM, Russo J. 1998. Increased expression of estrogen receptor-β in chemically transformed human breast epithelial cells. Int J Oncol 12: 12251228.
  • Huang Y, Bove B, Wu YL, Russo IH, Yang X, Zekri A, Russo J. 1999. Microsatellite instability during immortalization and transformation of human breast epithelial cells in vitro. Mol Carcinog 24: 118127.
  • Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558561.
  • Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G, Berstein L. 2000. Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 27: 95112.
  • Kelsey JL, Gammon MD, John EM. 1993. Reproductive factors and breast cancer. Epidemiol Rev 15: 3647.
  • Kerangueven F, Noguchi T, Wargniez V. 1996. Multiple sites of loss of heterozygosity on chromosome arms 3p and 3q in human breast carcinomas. Oncol Rep 3: 313316.
  • Koreth J, Bakkenist C, McGee JOD. 1997. Allelic deletions at chromosome 11q22–q23.1 and 11q25–q term are frequent in sporadic breast but not colorectal. Cancers Oncogene 14: 431437.
  • Lareef MH, Tahin Q, Russo IH, Mor G, Song J, Mihaila D, Slater CM, Russo J. 2001. Transfer of chromosome 17(p13.1) to chemically transformed human breast epithelial cells induces Fas-mediated apoptosis. Proc Am Assoc Cancer Res 42: 1475a.
  • Launonen V, Stenback F, Puistola U, Bloigu R, Huusko P, Kytola S, Kauppila A, Winqvist R. 1998. Chromosome 11q22.3–q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions. Gynecol Oncol 71: 299304.
  • Lippman ME, Huff KK, Jakesz R, Hecht T, Kasid A, Bates S, Dickson RB. 1986. Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer. In: AngeliA, BradlowHL, DogliottiL, editors. Endocrinology of the breast: basic and clinical aspects. New York: New York Academy of Sciences. p 1116.
  • Mackay J, Elder P, Porteous DI, Steel CM, Hawkins RA, Going JJ, Chetty U. 1988. Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and estrogen receptor level. Br J Cancer 58: 710714.
  • Man S, Ellis I, Sibbering M, Blarney R, Brook J. 1996. Highs level of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res 56: 54845489.
  • Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SM, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, Croce CM. 1995a. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 55: 30033007.
  • Negrini M, Sabbioni S, Ohta M, Veronese ML, Rattan S, Junien C, Croce CM. 1995b. Seven-megabase yeast artificial chromosome contig at region 11p15: identification of a yeast artificial chromosome spanning the breakpoint of a chromosomal translocation found in a case of Beckwith–Wiedmann syndrome. Cancer Res 55: 29042909.
  • Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM. 1996. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56: 31733179.
  • Pandis N, Bardi G, Mitelman F, Heim S. 1997. Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer 18: 241245.
  • Pike MC, Spicer DV, Dahmoush L, Press MF. 1993. Estrogens, progesterone, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 15: 1735.
  • Puech A, Henry I, Jeanpierre C, Junien C. 1991. A highly polymorphic probe on 11p15.5: L22.5.2 (D11S774). Nucleic Acids Res 19: 50955099.
  • Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H. 1995. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16p,17p and 17q. Cancer Res 55: 33993405.
  • Russo J, Reina D, Frederick J, Russo IH. 1988. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 48: 28372857.
  • Russo J, Calaf G, Russo IH. 1993a. A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. Crit Rev Oncog 44: 403417.
  • Russo J, Calaf G, Sohi N, Tahin Q, Zhang PL, Alvarado ME, Estrada S, Russo IH. 1993b. Critical steps in breast carcinogenesis. Ann N Y Acad Sci 698: 120.
  • Russo J, Barnabas N, Higgy N, Salicioni AM, Wu YL, Russo IH. 1996. Molecular basis of human breast epithelial cell transformation. In: CalvoF, CrepinM, MagdelenatH, editors. Breast cancer advances in biology and therapeutics. Paris: John Libbey Eurotext. p 3343.
  • Russo J, Hu YF, Yang X, Huang Y, Silva I, Bove B, Higgy N, Russo IH. 1998. Breast cancer multistage progression. Front Biosci 3: 944960.
  • Russo J, Hu YF, Yang X, Russo IH. 2000. Developmental, cellular, and molecular basis of breast cancer. J Natl Cancer Inst Monogr 27: 1738.
  • Russo J, Hu YF, Tahin Q, Mihaila, D, Slater C, Lareef HM, Russo IH. 2001. Carcinogenicity of estrogens in human breast epithelial cells. APMIS 109: 3952.
  • Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y. 1990. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 71847189.
  • Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. 1991. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51: 57945799.
  • Sato T, Saito H, Swensen J, Olifant A, Wood C, Danner D, Sakamoto T, Takita K, Kasumi F, Miki Y, Skolnick M, Nakamura Y. 1992. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 52: 16431646.
  • Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley R, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 60756086.
  • Swift M, Morrel D, Massey R, Chase C. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 18311836.
  • Tait L, Soule H, Russo J. 1990. Ultrastructural and immunocytochemical characterizations of an immortalized human breast epithelial cell line MCF-10. Cancer Res 50: 60876094.
  • Takita K-I, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y. 1992. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52: 39143917.
  • Theillet C, Lidereau R, Escot C, Hutzell P, Brunet M, Gest J, Schlom J, Callahan R. 1986. Loss of a c-H-ras-1 and aggressive human primary breast carcinomas. Cancer Res 46: 47764781.
  • Theillet C, Adnane J, Szepetowski P, Simon MP, Jeanteur P, Birnbaum D, Gaudray P. 1990. BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene 5: 147149.
  • Thibodeau SN, Bren G, Schaid D. 1993. Microsatellite instability in cancer of the proximal colon. Science 260: 816819.
  • Tomlinson IP, Nicolai H, Solomon E, Bodmer WF. 1996a. The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J Pathol 180: 3843.
  • Tomlinson IP, Beck NE, Bodmer WF. 1996b. Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. Eur J Cancer 32A: 17971802.
  • Topper YJ, Sankaran L, Chomczynski P, Prosser C, Qasba P. 1986. Three stages of responsiveness to hormones in the mammary cell. In: AngeliA, BradlowHL, DogliottiL, editors. Endocrinology of the breast: basic and clinical aspects. New York: New York Academy of Sciences. p 110.
  • Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN. 1997. BRCA1 proteins arc transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143157.
  • Weber JL, May PE. 1989. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 388396.
  • Wells AJ. 2000. Smoking and cancer in women. J Women's Cancer 2: 5566.
  • Westphal CH, Schmaltz C, Rowan S, Elson A, Fisher DE, Leder P. 1997. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res 57: 16641667.
  • Winqvist R, Mannermaa A, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee W. 1993. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res 53: 44864488.
  • Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaiko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I, Cavenee WK. 1995. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55: 26602664.
  • Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BA, von Deimling A, Wiestler OD, Cornelisse CJ, Devilee P, Stratton MR. 1994. Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet 6: 152156.
  • Wu Y, Barnabas N, Russo IH, Yang X, Russo J. 1997. Microsatellite instability and loss of heterozygosity in chromosomes 9 and 16 in human breast epithelial cells transformed by chemical carcinogens. Carcinogenesis 18: 10691074.
  • Yang X, Russo IH, Huang Y, Russo J. 1997. Microsatellite instability on chromosome 17 is associated with progression of breast cancer. Int J Oncol 11: 4146.
  • Yee CJ, Roodi N, Verrier CS, Parl FF. 1994. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54: 16411644.